Source: Bloomberg, 5:10

NYU senior fellow Ed Price reacts to comments from President Trump and Norway Prime Minister Jonas Støre as the leaders discuss the war in Ukraine and the status of peace negotiations. (Source: Bloomberg)

Ben Jensen, senior fellow at the Center for Strategic & International Studies, breaks down the latest on talks to end the war between Russia and Ukraine. (Source: Bloomberg)

John Hope Bryant, founder and CEO of Operation Hope Inc., discussed his meeting with treasury secretary Scott Bessent and said promoting financial literacy should be a unifying issue in the US. (Source: Bloomberg)

Clearlake Capital Group secured an extension from investors to gather $15 billion for its newest private equity fund, the latest sign of a difficult fundraising environment for buyout firms.

Two tech giants — Meta Platforms Inc. and Alphabet Inc. — were stung hard in antitrust trials in different rooms of the same federal courthouse this week. It’s a reflection of rare bipartisan enthusiasm for punishing them, efforts that spanned the Trump and Biden administrations.

President Donald Trump speaks with reporters at the White House about the state of US-Russia relations. (Source: Bloomberg)

Listen for the latest from Bloomberg News

Investment bankers are applauding steps taken by Canada’s securities regulators to make it easier to do initial public offerings, and to raise money afterwards.

Source: Bloomberg, 10:01

Source: Bloomberg, 45:03

Source: Bloomberg, 12:38

Hi, it’s Randall Williams in New York, reporting on how private equity firms are becoming popular partners for the owners of American sports teams. Elsewhere, Harvey Schwartz pushes Carlyle to revive its Washington brand in the Trump era.

Source: Bloomberg, 8:14

Source: Bloomberg, 8:04

Merck expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The company's first-quarter results beat estimates, with sales of $15.5 billion and adjusted earnings of $2.22 per share. Merck expects to launch an easier-to-use version of Keytruda later this year and is counting on new medicines to offset the impending decline of Keytruda. Merck's sales of Gardasil vaccine have fallen 41% in the first quarter, but the company is counting on new medicines, including a easier-to-use version of Keytruda, to offset the decline. Bloomberg's Damian Garde reports. (Source: Bloomberg)

Source: Bloomberg, 24:40

Gold’s returns are getting hard to ignore. The precious metal has been hitting record after record, with investors looking to safe-haven assets in the face of uncertain US economic policy.

Tariff-induced uncertainty has rapidly altered the cost of capital for companies across all sectors, with potential for wider spreads to persist. Carlos Mendez, Co-Founder and Managing Partner at Crayhill Capital Management, joins Bloomberg Intelligence’s Noel Hebert and Sam Geier on this episode of Credit Crunch to dive into the firm’s focus on commercial finance and renewable infrastructure asset-based lending, and the insulation its defensive approach provides. We discuss Crayhill’s recently

Source: Bloomberg, 5:01

Source: Bloomberg, 10:28

Source: Bloomberg, 17:22

Source: Bloomberg, 7:33

Source: Bloomberg, 12:22

Source: Bloomberg, 8:09

Source: Bloomberg, 10:29

Orders placed with US factories for business equipment barely rose in March, suggesting firms are growing cautious amid uncertainty surrounding tariffs and tax policy.

Source: Bloomberg, 6:59

Source: Bloomberg, 1:54